The mRNA technology, which has proved so crucial to the vaccine breakthroughs, was, at the time, also considered too experimental by Dr Phil Dormitzer, Pfizer’s vice-president and chief scientific officer for viral vaccines.
Categories
The mRNA technology, which has proved so crucial to the vaccine breakthroughs, was, at the time, also considered too experimental by Dr Phil Dormitzer, Pfizer’s vice-president and chief scientific officer for viral vaccines.